4-vinyl-1-cyclohexene dioxide has been researched along with kainic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorenzana, A; Schauwecker, PE; Wood, RI | 1 |
| Bhowmik, M; Pottoo, FH; Vohora, D | 1 |
2 other study(ies) available for 4-vinyl-1-cyclohexene dioxide and kainic acid
| Article | Year |
|---|---|
Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion.
Topics: Administration, Cutaneous; Animals; Brain; Carcinogens; Cell Death; Cyclohexenes; Disease Models, Animal; Estrogens; Excitatory Amino Acid Agonists; Female; Hippocampus; Histology; Injections, Intraperitoneal; Injections, Subcutaneous; Kainic Acid; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; Ovarian Follicle; Ovariectomy; Ovary; Seizures; Vinyl Compounds | 2009 |
Raloxifene protects against seizures and neurodegeneration in a mouse model mimicking epilepsy in postmenopausal woman.
Topics: Animals; Bone Density; Cyclohexenes; Disease Models, Animal; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Kainic Acid; Mice; Neurodegenerative Diseases; Neurons; Postmenopause; Raloxifene Hydrochloride; Seizures; Transforming Growth Factor beta3; Vinyl Compounds | 2014 |